Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the class of hydroquinolones and quinoline derivatives, with the chemical formula C18H22ClNO2 and a molecular weight of approximately 319.8 g/mol[1][7]. It is structurally characterized by a chloro group at position 6, a cyclohexyloxy group at position 4, and an isopropyl group at position 3 on the quinoline core[7]. This compound has been described as an experimental agent with potential biological activity but does not have established clinical use or well-characterized pharmacological properties. It has been referenced as "GW 557X" in some chemical databases and may have been investigated as a research tool or lead compound for further drug development[7][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-chloro-4-(cyclohexyloxy)-3-isopropylquinolin-2(1H)-one.